Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) February 22-25, 2016, Boston MA Back

2 Dapivirine Vaginal Ring Studies       CROI:A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women - (02/29/16)....37% protection.....61% if > 25 years old   CROI:Safety and Efficacy of Dapvirine Vaginal Ring for HIV-1 Prevention in African Women....31% reduction in HIV-infection....15% if <21 years old & 37% if >21 years old....analysis for better adherence found 65% protection   WEBCAST:http://www.croiwebcasts.org/console/player/29585?mediaType=audio&